Latest Breaking News On - Benjaminj hindson - Page 1 : comparemela.com

Eagle Asset Management Inc Trims Holdings in 10x Genomics, Inc (NASDAQ:TXG)

Eagle Asset Management Inc. trimmed its position in 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 0.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 729,476 shares of the company’s stock after selling 5,710 shares during the period. Eagle […]

United statesBenjaminj hindsonSerge saxonovStifel nicolausAsia pacificGenomics incAssociates corpGoldman sachs groupGroup ltdExchange commissionEagle asset management incSecurities exchange commissionEagle asset managementFree reportAsset managementNorth carolina

UBS Group Cuts 10x Genomics (NASDAQ:TXG) Price Target to $30 00

UBS Group Cuts 10x Genomics (NASDAQ:TXG) Price Target to $30 00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesBenjaminj hindsonAsia pacificSerge saxonovCanaccord genuity groupAssociates corpGenomics incAllspring global investments holdingsGoldman sachs groupGenomics company profileDeutsche bank aktiengesellschaftXponance incGroup ltdFree reportGenuity groupModerate buy

10x Genomics (NASDAQ:TXG) Releases Quarterly Earnings Results, Hits Expectations

10x Genomics (NASDAQ:TXG) Releases Quarterly Earnings Results, Hits Expectations
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesSerge saxonovAsia pacificBenjaminj hindsonGoldman sachs groupGenomics incCanaccord genuity groupGet free reportYahoo financeGenomics stockGenuity groupMiddle eastGenomics daily

Canaccord Genuity Group Lowers 10x Genomics (NASDAQ:TXG) Price Target to $50 00

10x Genomics (NASDAQ:TXG – Free Report) had its target price lowered by Canaccord Genuity Group from $65.00 to $50.00 in a report released on Monday, Benzinga reports. Canaccord Genuity Group currently has a buy rating on the stock. Several other equities analysts have also recently commented on TXG. Deutsche Bank Aktiengesellschaft decreased their price target […]

United statesBenjaminj hindsonSerge saxonovAsia pacificStifel nicolausHarvest fund management coCanaccord genuity groupGenomics incPowell investment advisorsDeutsche bank aktiengesellschaftGenomics company profileAssociates corpAllspring global investments holdingsFree reportGenuity groupBank aktiengesellschaft

10x Genomics (NASDAQ:TXG) Price Target Cut to $26 00 by Analysts at The Goldman Sachs Group

10x Genomics (NASDAQ:TXG – Free Report) had its price target reduced by The Goldman Sachs Group from $30.00 to $26.00 in a research report released on Wednesday, Benzinga reports. They currently have a sell rating on the stock. A number of other research firms also recently weighed in on TXG. TD Cowen downgraded shares of […]

United statesStifel nicolausBenjaminj hindsonSerge saxonovAsia pacificBleakley financial groupInvestment managementGenomics company profileSumitomo mitsui trust holdings incSecurities exchange commissionGenomics incVanguard group incDeutsche bank aktiengesellschaftCanaccord genuity groupGoldman sachs groupFree report